Skip to Primary Navigation

McKinsey OxyContin settlement illustrates need for robust comms surveillance and archiving

Purdue Pharma HQ in downtown Stamford, Connecticut. Purdue Pharma was the maker of OxyContin and a profitable McKinsey client. Photo by Drew Angerer/Getty Images

The matter-of-fact narrative is scathing of the moral and ethical void at Purdue as well as the behavior at the consulting firm.

In December we briefly reported on a significant DOJ fine of $650m against McKinsey & Company. This fine was levied as part of a criminal and civil settlement between the consulting firm and the DOJ in relation to the firm’s work with Purdue Pharma on the marketing and sale of